Lobbyist/Attorney
400 N. Capitol St., NW St. 585 Washington DC 20001, Washington, DC · KEVIN MCGUINESS
| Year | Client | Period | Income | Expenses | Doc |
|---|---|---|---|---|---|
| 2013 | TEVA PHARMACEUTICALS USA INC. |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$50,000 | — | |
| 2013 | MAJOR LEAGUE BASEBALL PLAYERS ASSOCIATION |
4th Quarter (Oct 1 - Dec 31) AMENDED |
— | — | |
| 2013 | MEDICARE SECONDARY PAYER COALITION |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$15,000 | — | |
| 2013 | RJR |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$25,000 | — | |
| 2013 | INTERNATIONAL AIDS VACCINE INITIATIVE |
4th Quarter (Oct 1 - Dec 31) 4th Quarter - Report |
$22,500 | — | |
| 2013 | INTERNATIONAL AIDS VACCINE INITIATIVE |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$22,500 | — | |
| 2013 | MEDICARE SECONDARY PAYER COALITION |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$16,125 | — | |
| 2013 | RJR |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$37,500 | — | |
| 2013 | TEVA PHARMACEUTICALS USA INC. |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
$25,000 | — | |
| 2013 | MAJOR LEAGUE BASEBALL PLAYERS ASSOCIATION |
3rd Quarter (July 1 - Sep 30) 3rd Quarter - Report |
— | — |
| Client | Filings | Total Income |
|---|---|---|
| RJR | 29 | $1,005,000 |
| MAJOR LEAGUE BASEBALL PLAYERS ASSOCIATION | 28 | $371,695 |
| TEVA PHARMACEUTICALS USA INC. | 25 | $737,500 |
| QLIANCE | 15 | $78,000 |
| THE GLOVER PARK GROUP | 13 | $256,500 |
| INTERNATIONAL AIDS VACCINE INITIATIVE | 12 | $206,000 |
| MEDICARE SECONDARY PAYER COALITION | 11 | $135,000 |
| AEGIS SCIENCES CORPORATION | 10 | $115,000 |
| BARR LABS | 7 | $260,000 |
| XM SATELLITE RADIO | 6 | $220,000 |
| FEDERATION OF AMERICAN HOSPITALS | 6 | $140,000 |
| HR POLICY ASSOCIATION | 5 | $30,000 |
| INTERNATIONAL COMMUNITY CORRECTIONS ASSOCIATION | 5 | $20,000 |
| TOSHIBA AMERICA INC | 4 | — |
| ASBESTOS STUDY GROUP | 3 | $30,000 |
| SNOCAP | 2 | $10,000 |
| Name | Disclosed Prior Position |
|---|---|
| KEVIN MCGUINESS | N/A |